Letters

Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.

Latest

AHA Nov. 5 sent a letter to the Centers for Medicare & Medicaid Services with recommendations for implementing specific provisions in the OBBBA.
The American Hospital Association (AHA) expresses support for the Home Health Stabilization Act of 2025 (H.R. 5142).
AHA and other health organizations urge Congress to protect patient access to clinical laboratory services by enacting needed reforms to the Medicare Clinical Laboratory Fee Schedule (CLFS).
The American Hospital Association (AHA) provides comments on the Office of Science and Technology Policy (OSTP) request for information regarding regulatory reform on artificial intelligence (AI).
The American Hospital Association comments on the Department of Homeland Security’s proposed weighted selection process for registrants and petitioners seeking to file cap-subject H-1B petitions.
October 23, 2025
the American Hospital Association thanks the Federal Trade Commission (FTC) for dismissing its appeals in Ryan, LLC v. FTC, No. 24-10951 (5th Cir.), and Properties of the Villages v. FTC, No. 24-13102 (11th Cir.), and acceding to the vacatur of the Non-Compete Clause Rule.
AHA comments on the Department of Commerce’s request for public comment on its Section 232 national security investigation on personal protective equipment (PPE), medical consumables and medical equipment.
AHA comments on the Medicare Payment Advisory Commission’s preliminary analysis of the association between Medicare Advantage (MA) enrollment changes and hospital finances shared during the September public meeting.
AHA comments on the Health Resources and Services Administration’s (HRSA) information collection request (ICR) regarding the expected costs of its 340B Rebate Model Pilot Program.